Glyciphosphoramide is a DNA crosslinking agent with anticancer activity. Glyciphosphoramide (GPA) belongs to the group of phosphoramide mustard anticancer agents. It has apparent antitumor effects in some animal models and in clinical trials against breast cancer, lymphosarcoma, uterocervical cancer and cancerous ulcer with good results. References: Wang WJ, Bai JY, Zhu XY. [Determination of glyciphosphoramide and its metabolite in plasma and the pharmacokinetics in rats after oral administration]. Yao Xue Xue Bao. 1993;28(10):738-43. Chinese. PubMed PMID: 8009985.

纯度：≥98%

CAS：7568-40-3